Aripiprazole in Children and Adolescents With Bipolar Disorder and ADHD: A Randomized Double Blind Placebo Controlled Trial

Next Previous
Trial Profile

Aripiprazole in Children and Adolescents With Bipolar Disorder and ADHD: A Randomized Double Blind Placebo Controlled Trial

Completed
Phase of Trial: Phase III

Latest Information Update: 01 May 2009

At a glance

  • Drugs Aripiprazole (Primary)
  • Indications Attention-deficit hyperactivity disorder; Bipolar disorders; Bipolar I disorders; Bipolar II disorders
  • Focus Therapeutic Use

    • Most Recent Events

    • 06 Aug 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov
    • 23 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top